Infectious Vaccines Market Size, Trends, Analysis, and Outlook By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030
The global Infectious Vaccines market size is poised to register 6.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Infectious Vaccines market across By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution).
The infectious vaccines market is witnessing steady growth, driven by increasing awareness of vaccine-preventable diseases, expanding vaccination programs, and advancements in vaccine development and delivery technologies. Infectious vaccines play a crucial role in protecting individuals and populations against a wide range of bacterial, viral, and parasitic pathogens, reducing the incidence of morbidity, mortality, and transmission of infectious diseases worldwide. With a growing emphasis on immunization coverage, vaccine equity, and pandemic preparedness, governments, public health agencies, and non-profit organizations are investing in the development, production, and distribution of vaccines to address global health priorities such as COVID-19, influenza, measles, polio, and pneumococcal disease. Moreover, advancements in vaccine platform technologies, adjuvant systems, and formulation strategies are driving market expansion, offering new opportunities for vaccine developers to improve vaccine efficacy, safety, and stability, and overcome challenges such as cold chain storage and vaccine hesitancy. Additionally, collaborations between vaccine manufacturers, research institutions, and international organizations are driving innovation in infectious vaccines, fostering the development of new vaccine candidates, novel delivery systems, and combination vaccines to address unmet medical needs and public health challenges in diverse populations and settings.
Infectious Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Infectious Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Infectious Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Infectious Vaccines industry.
Key market trends defining the global Infectious Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Infectious Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Infectious Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Infectious Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Infectious Vaccines industry
Leading Infectious Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Infectious Vaccines companies.
Infectious Vaccines Market Study- Strategic Analysis Review
The Infectious Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Infectious Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Infectious Vaccines Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Infectious Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Infectious Vaccines market segments. Similarly, Strong end-user demand is encouraging Canadian Infectious Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Infectious Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Infectious Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Infectious Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Infectious Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Infectious Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Infectious Vaccines in Asia Pacific. In particular, China, India, and South East Asian Infectious Vaccines markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Infectious Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Infectious Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Infectious Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Infectious Vaccines.
Infectious Vaccines Market Company Profiles
The global Infectious Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AstraZeneca, BioNTech SE, GSK Plc, Merck & Co. Inc, Moderna Inc, Pfizer Inc, Sanofi, Seqirus, Serum Institute of India Pvt. Ltd, Sinovac
Recent Infectious Vaccines Market Developments
The global Infectious Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Infectious Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Inactivated Vaccines
Live Attenuated Vaccines
DNA and Recombinant Vector Vaccines
Others
By Disease
Typhoid
Tuberculosis
Tetanus and Diphtheria
Influenza
Hepatitis
Polio
Others
By Distribution Channel
Hospitals
Retail Pharmacies
Online Distribution
Geographical Segmentation:
AstraZeneca
BioNTech SE
GSK Plc
Merck & Co. Inc
Moderna Inc
Pfizer Inc
Sanofi
Seqirus
Serum Institute of India Pvt. Ltd
Sinovac
Formats Available: Excel, PDF, and PPT
The infectious vaccines market is witnessing steady growth, driven by increasing awareness of vaccine-preventable diseases, expanding vaccination programs, and advancements in vaccine development and delivery technologies. Infectious vaccines play a crucial role in protecting individuals and populations against a wide range of bacterial, viral, and parasitic pathogens, reducing the incidence of morbidity, mortality, and transmission of infectious diseases worldwide. With a growing emphasis on immunization coverage, vaccine equity, and pandemic preparedness, governments, public health agencies, and non-profit organizations are investing in the development, production, and distribution of vaccines to address global health priorities such as COVID-19, influenza, measles, polio, and pneumococcal disease. Moreover, advancements in vaccine platform technologies, adjuvant systems, and formulation strategies are driving market expansion, offering new opportunities for vaccine developers to improve vaccine efficacy, safety, and stability, and overcome challenges such as cold chain storage and vaccine hesitancy. Additionally, collaborations between vaccine manufacturers, research institutions, and international organizations are driving innovation in infectious vaccines, fostering the development of new vaccine candidates, novel delivery systems, and combination vaccines to address unmet medical needs and public health challenges in diverse populations and settings.
Infectious Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Infectious Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Infectious Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Infectious Vaccines industry.
Key market trends defining the global Infectious Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Infectious Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Infectious Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Infectious Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Infectious Vaccines industry
Leading Infectious Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Infectious Vaccines companies.
Infectious Vaccines Market Study- Strategic Analysis Review
The Infectious Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Infectious Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Infectious Vaccines Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Infectious Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Infectious Vaccines market segments. Similarly, Strong end-user demand is encouraging Canadian Infectious Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Infectious Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Infectious Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Infectious Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Infectious Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Infectious Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Infectious Vaccines in Asia Pacific. In particular, China, India, and South East Asian Infectious Vaccines markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Infectious Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Infectious Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Infectious Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Infectious Vaccines.
Infectious Vaccines Market Company Profiles
The global Infectious Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AstraZeneca, BioNTech SE, GSK Plc, Merck & Co. Inc, Moderna Inc, Pfizer Inc, Sanofi, Seqirus, Serum Institute of India Pvt. Ltd, Sinovac
Recent Infectious Vaccines Market Developments
The global Infectious Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Infectious Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Inactivated Vaccines
Live Attenuated Vaccines
DNA and Recombinant Vector Vaccines
Others
By Disease
Typhoid
Tuberculosis
Tetanus and Diphtheria
Influenza
Hepatitis
Polio
Others
By Distribution Channel
Hospitals
Retail Pharmacies
Online Distribution
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AstraZeneca
BioNTech SE
GSK Plc
Merck & Co. Inc
Moderna Inc
Pfizer Inc
Sanofi
Seqirus
Serum Institute of India Pvt. Ltd
Sinovac
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Infectious Vaccines Market Overview and Key Findings, 2024
1.2 Infectious Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Infectious Vaccines Market Growth Opportunities to 2030
1.4 Key Infectious Vaccines Market Trends and Challenges
1.4.1 Infectious Vaccines Market Drivers and Trends
1.4.2 Infectious Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Infectious Vaccines Companies
2. INFECTIOUS VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Infectious Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Infectious Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INFECTIOUS VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INFECTIOUS VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Inactivated Vaccines
Live Attenuated Vaccines
DNA and Recombinant Vector Vaccines
Others
By Disease
Typhoid
Tuberculosis
Tetanus and Diphtheria
Influenza
Hepatitis
Polio
Others
By Distribution Channel
Hospitals
Retail Pharmacies
Online Distribution
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Infectious Vaccines Market, 2025
5.2 Asia Pacific Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Infectious Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Infectious Vaccines Market, 2025
5.5 Europe Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Infectious Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Infectious Vaccines Market, 2025
5.8 North America Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Infectious Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Infectious Vaccines Market, 2025
5.11 South America Pacific Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Infectious Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Infectious Vaccines Market, 2025
5.14 Middle East Africa Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Infectious Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Infectious Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Infectious Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Infectious Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Infectious Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Infectious Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Infectious Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Infectious Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Infectious Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Infectious Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Infectious Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Infectious Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Infectious Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Infectious Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Infectious Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Infectious Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Infectious Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Infectious Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Infectious Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Infectious Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Infectious Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Infectious Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Infectious Vaccines Industry Drivers and Opportunities
7. INFECTIOUS VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INFECTIOUS VACCINES COMPANY PROFILES
8.1 Profiles of Leading Infectious Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AstraZeneca
BioNTech SE
GSK Plc
Merck & Co. Inc
Moderna Inc
Pfizer Inc
Sanofi
Seqirus
Serum Institute of India Pvt. Ltd
Sinovac
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Infectious Vaccines Market Overview and Key Findings, 2024
1.2 Infectious Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Infectious Vaccines Market Growth Opportunities to 2030
1.4 Key Infectious Vaccines Market Trends and Challenges
1.4.1 Infectious Vaccines Market Drivers and Trends
1.4.2 Infectious Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Infectious Vaccines Companies
2. INFECTIOUS VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Infectious Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Infectious Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. INFECTIOUS VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. INFECTIOUS VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Inactivated Vaccines
Live Attenuated Vaccines
DNA and Recombinant Vector Vaccines
Others
By Disease
Typhoid
Tuberculosis
Tetanus and Diphtheria
Influenza
Hepatitis
Polio
Others
By Distribution Channel
Hospitals
Retail Pharmacies
Online Distribution
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Infectious Vaccines Market, 2025
5.2 Asia Pacific Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Infectious Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Infectious Vaccines Market, 2025
5.5 Europe Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Infectious Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Infectious Vaccines Market, 2025
5.8 North America Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Infectious Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Infectious Vaccines Market, 2025
5.11 South America Pacific Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Infectious Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Infectious Vaccines Market, 2025
5.14 Middle East Africa Infectious Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Infectious Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Infectious Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Infectious Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Infectious Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Infectious Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Infectious Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Infectious Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Infectious Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Infectious Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Infectious Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Infectious Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Infectious Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Infectious Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Infectious Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Infectious Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Infectious Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Infectious Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Infectious Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Infectious Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Infectious Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Infectious Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Infectious Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Infectious Vaccines Industry Drivers and Opportunities
7. INFECTIOUS VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. INFECTIOUS VACCINES COMPANY PROFILES
8.1 Profiles of Leading Infectious Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AstraZeneca
BioNTech SE
GSK Plc
Merck & Co. Inc
Moderna Inc
Pfizer Inc
Sanofi
Seqirus
Serum Institute of India Pvt. Ltd
Sinovac
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
